Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rallybio Corp (RLYB) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rallybio Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1739410.
Total stock buying since 2021: $39,335,298.
Total stock sales since 2021: $13,470,998.
Total stock option exercises since 2021: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 5,000 | $26,050 | 200,000 | $1,639,998 | 0 | $0 |
2022 | 34,400 | $331,270 | 920,000 | $11,831,000 | 0 | $0 |
2021 | 2,998,306 | $38,977,978 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-03 | 5,000 | $26,050 | 200,000 | $1,639,998 | 0 | $0 |
2022-06 | 0 | $0 | 300,000 | $3,750,000 | 0 | $0 |
2022-05 | 0 | $0 | 200,000 | $2,600,000 | 0 | $0 |
2022-03 | 3,000 | $24,119 | 0 | $0 | 0 | $0 |
2022-02 | 0 | $0 | 420,000 | $5,481,000 | 0 | $0 |
2022-01 | 31,400 | $307,151 | 0 | $0 | 0 | $0 |
2021-08 | 2,192,306 | $28,499,978 | 0 | $0 | 0 | $0 |
2021-07 | 806,000 | $10,478,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-03-14 | Lieber Jonathan I (See Remarks) | Buy | 5,000 | 5.21 | 26,050 |
2023-03-07 | Parmar Kush (Director) | Sale | 100,000 | 8.20 | 819,999 |
2023-03-07 | Rocklage Scott M (10% Owner) | Sale | 100,000 | 8.20 | 819,999 |
2022-06-03 | Parmar Kush (Director) | Sale | 150,000 | 12.50 | 1,875,000 |
2022-06-03 | Rocklage Scott M (10% Owner) | Sale | 150,000 | 12.50 | 1,875,000 |
2022-05-23 | Parmar Kush (Director) | Sale | 100,000 | 13.00 | 1,300,000 |
2022-05-23 | Rocklage Scott M (10% Owner) | Sale | 100,000 | 13.00 | 1,300,000 |
2022-03-21 | Fryer Jeffrey M (See Remarks) | Buy | 3,000 | 8.04 | 24,119 |
2022-02-08 | Parmar Kush (Director) | Sale | 210,000 | 13.05 | 2,740,500 |
2022-02-08 | Rocklage Scott M (10% Owner) | Sale | 210,000 | 13.05 | 2,740,500 |
2022-01-19 | Fryer Jeffrey M (See Remarks) | Buy | 1,400 | 8.70 | 12,179 |
2022-01-13 | Uden Stephen (See Remarks) | Buy | 5,000 | 9.34 | 46,700 |
2022-01-12 | Uden Stephen (See Remarks) | Buy | 5,000 | 10.55 | 52,750 |
2022-01-11 | Mackay Martin (Chief Executive Officer) | Buy | 4,496 | 10.65 | 47,882 |
2022-01-10 | Mackay Martin (Chief Executive Officer) | Buy | 5,504 | 10.10 | 55,590 |
2022-01-07 | Fryer Jeffrey M (See Remarks) | Buy | 10,000 | 9.21 | 92,050 |
2021-08-02 | Parmar Kush (Director) | Buy | 615,384 | 13.00 | 7,999,992 |
2021-08-02 | Hopfner Robert Lorne (Director) | Buy | 576,923 | 13.00 | 7,499,999 |
2021-08-02 | Hunt Ronald (Director) | Buy | 307,692 | 13.00 | 3,999,996 |
2021-08-02 | Rocklage Scott M (10% Owner) | Buy | 615,384 | 13.00 | 7,999,992 |
2021-08-02 | Shannon Timothy M (Director) | Buy | 76,923 | 13.00 | 999,999 |
2021-07-29 | Shabet Rose Sharon | Buy | 806,000 | 13.00 | 10,478,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RLYB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rallybio Corp (symbol RLYB, CIK number 1739410) see the Securities and Exchange Commission (SEC) website.